News about Market

Bayer Files Japan Application to Expand Finerenone Use in Non-Diabetic CKD

Bayer’s Japan filing, backed by Phase III FIND-CKD data showing slower kidney function decline and a 23 percent reduction in cardiovascular-kidney events, seeks to expand finerenone’s potential role in treating adults with non-diabetic CKD and addressing a significant unmet medical need.

Market | 31/08/2026 | By News Bureau

Entod Pharmaceuticals Launches Project AXIOM to Explore Novel Myopia Therapy

Entod Pharmaceuticals has launched Project AXIOM, an India-led research programme exploring retinal dopaminergic modulation as a potential approach to slowing progressive myopia.

Market | 27/08/2026 | By News Bureau

Agilent Reports Third-Quarter Fiscal Year 2026 Financial Results

Agilent Technologies reports strong third-quarter fiscal 2026 results and raises its FY26 revenue growth, margin expansion and non-GAAP EPS guidance.

Market | 27/08/2026 | By News Bureau |  144

ASPA and CRISIL Report Finds 89 Percent of Consumers Have Purchased Counterfeit Products in India

ASPA’s latest report highlights the widespread presence of counterfeit products across key sectors, urging brands, regulators and consumers to strengthen authentication and traceability efforts.

Market | 26/08/2026 | By News Bureau |  182

Aptus Pharma Charts Next Growth Phase with Focus on Manufacturing, Pan-India Expansion and Global Markets

Aptus Pharma plans its next growth phase with a INR 44.88 crore preferential equity issue, focusing on manufacturing, pan-India expansion and global markets.

Market | 24/08/2026 | By News Bureau

Glenmark Launches Calcium Gluconate Injection in US

Glenmark launches Calcium Gluconate Injection USP in the US, offering a bioequivalent and therapeutically equivalent alternative to Fresenius Kabi’s reference drug.

Market | 21/08/2026 | By News Bureau

Mankind Pharma In-Licenses Two Insulin Analogues from China for Indian Market

Mankind Pharma has signed an exclusive in-licensing and marketing agreement with China-based Chongqing Chenan Biopharmaceutical for Insulin Degludec and Insulin Degludec plus Aspart combination in India, strengthening its injectable diabetes portfolio.

Market | 20/08/2026 | By News Bureau |  110

Symbiotec Pharmalab to Open IPO for Subscription on August 24, 2026

Symbiotec Pharmalab will open its IPO for subscription from August 24–27, 2026, with a price band of INR 938–INR 988 per share and an OFS component of up to INR 1,607 crore.

Market | 20/08/2026 | By News Bureau |  142

Glenmark Pharmaceuticals Receives US FDA Approval for Fluticasone Propionate Nasal Spray

Glenmark Pharmaceuticals receives US Food and Drug Administration (FDA) approval for Fluticasone Propionate Nasal Spray, a bioequivalent and therapeutically equivalent generic of Flonase Nasal Spray.

Market | 20/08/2026 | By News Bureau

Lupin and Tenpoint Therapeutics Announce Strategic Partnership to Commercialise YUVEZZI in Europe

Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI in the European Union (EU), The UK, Switzerland, Norway, and Iceland and expand access to the once-daily dual-agent eye drop for presbyopia.

Market | 20/08/2026 | By News Bureau |  102